Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Published on by Forensic Scientist

Prof. Yuyan Tang | Immunology and Microbiology | Best Researcher Award

Minhang Hospital, Fudan University | China

Prof. Yuyan Tang is a clinician-scientist specializing in nephrology and molecular immunopathology, with a strong research focus on the gut–kidney axis, IgA nephropathy, and chronic kidney disease (CKD). Her studies elucidate the mechanisms by which intestinal microbiota, short-chain fatty acids (SCFAs), and NLRP3 inflammasome signaling influence renal inflammation and fibrosis, integrating molecular biology with traditional Chinese medicine interventions. She has led several competitive research projects funded by the National Natural Science Foundation of China and regional scientific bodies, advancing translational insights into renal disease mechanisms and microbiome-based therapeutic strategies. Prof. Yuyan Tang has published 23 peer-reviewed documents indexed in Scopus, garnering 287 citations across 262 citing documents, with an h-index of 8. Her scientific contributions include 8 first- or corresponding-author SCI papers with a total impact factor of 52.7, notably featuring a highly cited article in Circulation Research and impactful publications in Nephrology Dialysis Transplantation and BMC Microbiology. Recognized as a Youth Talent Awardee at Fudan University’s Affiliated Minhang Hospital, Prof. Yuyan Tang’s research continues to bridge microbiome regulation and nephrology through innovative molecular and clinical investigations.

Profile: Scopus

Featured Publications

  • Tang, Y., Zhu, Y., He, H., Sun, W., Wu, J., Xiao, Y., … Xu, X. (2024). IgA nephropathy: Gut microbiome regulates the production of hypoglycosylated IgA1 via the TLR4 signaling pathway. Nephrology Dialysis Transplantation, 39(10), 1624–1641.

  • Jiang, L., He, H., Tang, Y., Li, J., Reilly, S., Xin, H., … Cai, H. (2024). Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy. Autophagy, 20(11), 2388–2404.

  • Li, H., Xu, M., Xu, X., Tang, Y., Jiang, H., Li, L., … Yang, T. (2022). Faecalibacterium prausnitzii attenuates CKD via Butyrate-Renal GPR43 Axis. Circulation Research, 131(9), e120–e134.

  • Tang, Y., Xiao, Y., He, H., Zhu, Y., Sun, W., Hu, P., … Xu, X. (2023). Aberrant gut microbiome contributes to barrier dysfunction, inflammation and local immune responses in IgA nephropathy. Kidney and Blood Pressure Research, 48(1), 261–276.

  • Tang, Y., Zhu, Y., He, H., Peng, Y., Hu, P., Wu, J., … Xu, X. (2022). Gut dysbiosis and intestinal barrier dysfunction promote IgA nephropathy by increasing the production of Gd-IgA1. Frontiers in Medicine, 9, 944027.

Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Published on by Forensic Scientist

Mrs. Monika Prylińska-Jaśkowiak | Immunology and Microbiology | Young Scientist Award

Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University | Poland

Mrs. Monika Prylińska-Jaśkowiak is an emerging clinician-scientist whose professional journey reflects a rare balance between medical practice, academic excellence, and translational research. She earned her Doctor of Medical Sciences degree from Collegium Medicum, Nicolaus Copernicus University in Toruń, where her doctoral research focused on the relationship between the gut microbiome and chronic fatigue syndrome, integrating clinical insight with advanced molecular and bioinformatic analyses. As a specialist pediatrician at the Voivodeship Children’s Hospital in Bydgoszcz, she combines her research background with everyday patient care and is currently pursuing specialization in pediatric rheumatology. Her scientific contributions include peer-reviewed publications such as The gut microbial composition is different in chronic fatigue syndrome than in healthy controls (Scientific Reports, 2025), and review papers in the Journal of Education, Health and Sport (2022), widely cited for summarizing current knowledge on CFS/ME and human gut microbiota. Mrs. Monika Prylińska-Jaśkowiak’s research interests encompass pediatric immunology, microbiome–immune interactions, and chronic inflammatory diseases, with a focus on precision diagnostics and targeted therapy development. Actively engaged in professional societies including the Polish Pediatric Society and the Polish Society of Vaccinology, she continues to expand her expertise through certified courses in resuscitation, vaccinology, and emergency pediatrics. Her commitment to continuous learning, clinical excellence, and evidence-based innovation exemplifies the spirit of a modern physician-scientist dedicated to improving child health and advancing medical science.

Profile: ORCID | LinkedIn

Featured Publications

• Prylińska, M., & Kożuchowski, M. (2022, September 28). The human gastrointestinal tract microbiota in health – current knowledge summary. Journal of Education, Health and Sport, 12(10). https://doi.org/10.12775/JEHS.2022.12.10.005

• Kożuchowski, M., & Prylińska, M. (2022, April 30). The proper functioning of the sense of smell and its disturbances on the example of COVID-19 infection. Journal of Education, Health and Sport, 12(4). https://doi.org/10.12775/JEHS.2022.12.04.026

Majid Taati Moghadam | Immunology and Microbiology | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Majid Taati Moghadam | Immunology and Microbiology | Best Researcher Award

Guilan University of Medical Sciences | Iran

Dr. Majid Taati Moghadam is a dedicated Medical Microbiologist and Antimicrobial Resistance Researcher based in Rasht, Iran. He specializes in microbial pathogenesis, antibiotic resistance mechanisms, bacteriophage therapy, and the connection between microbiota and neurodegenerative disorders. His multidisciplinary expertise extends across clinical microbiology, infectious disease prevention, and translational therapeutics, making him a leading figure in Iran’s microbiological research community.

Professional Profile

Scopus

Google Scholar

ORCID

Education

Dr. Majid Taati holds a Ph.D. in Medical Bacteriology from Iran University of Medical Sciences (2017–2022), where his research investigated the relationship between oral microbiome shifts and Alzheimer’s disease. He earned his Master’s degree in Medical Microbiology from Kerman University of Medical Sciences (2012–2015), focusing on carbapenem resistance genes in Klebsiella pneumoniae. His academic journey began with a Bachelor’s degree in Microbiology from Islamic Azad University, Lahijan Branch (2007–2012). Throughout his studies, he demonstrated a keen interest in antibiotic resistance, clinical diagnostics, and the molecular biology of pathogens.

Experience

Dr. Majid Taati has played key roles in over a dozen microbiological research projects across Iran. As both a principal investigator and main collaborator, he has contributed to studies on extended-spectrum beta-lactamase (ESBL) genes, resistance enzymes in E. coli, and the antimicrobial effects of plant extracts like Ephedra pachyclada. He has worked extensively on projects involving nosocomial infections, multidrug-resistant bacteria, and genetic analysis methods such as MLVA and HRM techniques. He also authored the textbook Essential Medical Microbiology in Persian, and presented his findings at several major Iranian congresses, including the International Microbiology Congress. His laboratory and academic experience bridges both applied research and educational leadership.

Research Interests

Dr. Majid Taati research focuses on antimicrobial resistance mechanisms, phage and endolysin therapy, bacterial biofilm inhibition, and engineered phage enzymes for resistant infections. He is also deeply involved in exploring the role of microbiota in neurological and neuropsychiatric disorders, especially Alzheimer’s disease. His studies aim to bridge clinical microbiology with therapeutic innovation addressing global health threats posed by superbugs like carbapenem- and colistin-resistant Gram-negative bacteria. His recent projects extend to wound healing biomaterials, phage protein therapies, and microbiome-based diagnostics, reflecting his broad and multidisciplinary scientific interests.

Awards

Recognized for his extensive research contributions, Dr. Majid Taati is a deserving nominee for the “Best Researcher Award” in medical microbiology and antimicrobial resistance. His scholarly excellence, particularly in phage therapy and resistance gene profiling, aligns well with the objectives of scientific bodies that honor groundbreaking research. With dozens of publications in top-tier journals and continuous involvement in nationally significant projects, he exemplifies leadership in translational microbiology and global infectious disease research.

Publications

  • Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
    Year: 2020
    Citations: 316

  • Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
    Year: 2020
    Citations: 311

  • How phages overcome the challenges of drug resistant bacteria in clinical infections
    Year: 2020
    Citations: 173

  • Bacteriophages, a new therapeutic solution for inhibiting multidrug-resistant bacteria causing wound infection: lesson from animal models and clinical trials
    Year: 2020
    Citations: 125

  • COVID-19 (Coronavirus disease 2019): a new coronavirus disease
    Year: 2020
    Citations: 108

  • Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from clinical samples
    Year: 2019
    Citations: 108

  • Bacteriophage as a novel therapeutic weapon for killing colistin-resistant multi-drug-resistant and extensively drug-resistant gram-negative bacteria
    Year: 2021
    Citations: 58

Conclusion

Dr. Majid Taati Moghaddam Ziabari has built an impressive career defined by scientific innovation, deep academic rigor, and a commitment to combating infectious diseases. His pioneering work in bacteriophage therapy and antimicrobial resistance not only advances microbiological science but also addresses some of the most urgent global health challenges. With his rich publication record, research leadership, and academic influence, he is a prime candidate for international recognition, especially the Best Researcher Award. His career serves as a model of excellence in translational research and academic impact.

Ji Li | Medicine and Health Sciences | Best Scholar Award

Published on by Forensic Scientist

Prof. Ji Li | Medicine and Health Sciences | Best Scholar Award

Central South University | China

Professor Ji Li, PhD, is a distinguished scholar in dermatological sciences, currently serving in the Department of Dermatology at Xiangya Hospital, Central South University, China. Renowned for groundbreaking research in inflammatory dermatosis and skin aging, Professor Ji has significantly advanced clinical and molecular dermatology through over a decade of academic contributions.

Author Profile👤

Scopus

Strengths for the Awards✨

Professor Ji Li, PhD, has firmly established herself as a leading figure in dermatological research, particularly in the areas of inflammatory dermatosis and skin aging. Her academic contributions are highly impactful, with over 100 SCI-indexed publications in prestigious international journals, such as BMJ, Science Advances, Developmental Cell, EMBO Journal, JAAD, JAMA Dermatology, and Journal of Investigative Dermatology. This extensive publication record underscores her sustained productivity and global recognition.

In addition to scholarly output, her ability to attract six projects funded by the National Natural Science Foundation of China (NSFC) demonstrates her competence in leading significant, peer-reviewed scientific research with national and institutional importance. Her dual roles as first and corresponding author reflect intellectual leadership and mentorship capability, making her a strong candidate for the Best Scholar Award.

🎓 Education

Professor Ji Li earned a Ph.D. in Dermatology and has since cultivated a strong academic foundation that supports both clinical excellence and scientific innovation. Their academic journey is rooted in top-tier institutions, combining rigorous research training with a focus on translational skin biology.

🧪 Experience

With a long-standing tenure at Xiangya Hospital, Professor Ji Li has blended clinical dermatology practice with laboratory-based investigation, leading several research groups and mentoring young scientists. With active involvement in national and international dermatological communities, Ji Li is recognized as a clinical-scientific leader in the field.

🔬 Research Interest On Medicine and Health Sciences

Professor Ji’s core research areas include:

  • Inflammatory dermatoses, exploring molecular mechanisms and treatment strategies

  • Skin aging, investigating cellular aging pathways and potential rejuvenation therapies
    These interests are supported by a rich body of work that bridges clinical needs and molecular science.

🏆 Award

Professor Ji Li has been honored with several prestigious recognitions, including grants from the National Natural Science Foundation of China (with 6 funded projects), underlining the scientific community’s acknowledgment of Ji’s excellence and innovation. The consistent impact of Ji’s work positions them as a leading nominee for the Best Scholar Award.

📚 Publications

Professor Ji Li has authored over 100 SCI-indexed papers as first or corresponding author, published in top-tier international journals. Notable recent publications include:

💡 Conclusion

Professor Ji Li exemplifies the values of the Best Scholar Award through a rare combination of clinical expertise, scientific vision, and impactful scholarship. With extensive contributions to inflammatory skin diseases and aging, an outstanding publication record, and robust grant support, Ji stands out as a trailblazer in dermatology research. Their leadership continues to inspire innovation, mentorship, and global collaboration.

Zhongzhen Su | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Zhongzhen Su | Medicine | Best Researcher Award

The Fifth Affiliated Hospital of Sun Yat-sen University |China

Dr. Zhongzhen Su is a renowned medical professional with over two decades of expertise in abdominal ultrasound diagnosis and liver cancer interventional therapy. Currently serving as the Director of the Ultrasound Medicine Department at the Fifth Affiliated Hospital of Sun Yat-sen University, he has made pivotal contributions in early liver cancer detection and fibrosis assessment. Recognized as a “High-level Talent in Zhuhai” and a “Guangdong Outstanding Young Medical Talent”, Dr. Su has significantly enhanced survival outcomes for cirrhotic patients through innovative imaging techniques.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Established Academic and Research Record:

    • 48 SCI publications with an H-index of 28 and 1,000+ citations, indicating consistent and influential contributions.

    • Highest publication impact factor of 14.3, demonstrating recognition in high-quality journals.

  2. Innovative Contributions:

    • Two patents (e.g., tumor ultrasound phantom, fibrosis prediction model) and innovative developments in liver cancer diagnostics and ablation.

    • Led 18 completed and 1 ongoing research projects, including National Natural Science Foundation grants.

  3. Clinical and Educational Impact:

    • Pioneered early detection and ultrasound-guided treatment of liver cancer, improving survival rates.

    • Trained over 50 postgraduates, indicating a significant contribution to academic mentorship.

  4. Recognitions and Leadership:

    • Recognized as a “High-level Talent in Zhuhai” and “Guangdong Outstanding Young Medical Talent”.

    • Serves as Director of Ultrasound Medicine and holds leadership roles in national professional associations.

  5. Interdisciplinary and AI Integration:

    • Engaged in AI-based fibrosis assessment and multicenter collaborations, showcasing forward-looking research alignment.

🎓 Education

Dr. Zhongzhen Su earned his Ph.D. in Imaging and Nuclear Medicine from Sun Yat-sen University, one of China’s top medical institutions. His academic foundation combines clinical depth with scientific rigor, forming the bedrock for his ongoing advancements in ultrasound-guided interventions and diagnostic radiology.

👨‍⚕️ Experience

With over 20 years of clinical and academic experience, Dr. Zhongzhen Su has held key roles, including Deputy Dean of the Fifth Affiliated Hospital and now Director of Ultrasound Medicine. His leadership has been instrumental in establishing state-of-the-art interventional ultrasound programs, supervising over 50 postgraduates, and leading multicenter clinical trials focused on liver health.

🔬 Research Interest On Medicine

Dr. Zhongzhen Su primary research interests lie in abdominal ultrasound diagnosis, interventional ultrasound for liver cancer, quantitative assessment of liver fibrosis, and post-ablation evaluation techniques. He is also exploring AI-based models for early-stage fibrosis and cancer detection, which promise transformative impacts in personalized medicine.

🏆 Awards

Dr. Zhongzhen Su is a three-time recipient of the Guangdong Science and Technology Awards 🏅, reflecting his leadership in ultrasound-guided interventional innovation. He has also been honored as a “High-level Talent in Zhuhai” and a “Guangdong Outstanding Young Medical Talent”, distinctions reserved for top-tier professionals in the region’s medical community.

📚 Publications

1. Nomogram Using Bi-modal Imaging for Predicting Low-level HER2 Expression Status in Breast Cancer

  • Authors: Xingyu Liang, Jiamin Chen, Jiawei Tian, Xin Wen

  • Journal: European Journal of Radiology

  • Year: 2025

2. Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients

  • Authors: Yu Li, Sheng Li, Qing Li, Lingling Li, Jianhua Zhou

  • Journal: Korean Journal of Radiology

  • Year: 2025

  • Citations: 0​

3. Doppler Ultrasound Imaging and Shear Wave Elastography for Evaluation of Interstitial Fibrosis/Tubular Atrophy in IgA Nephropathy

  • Authors: Jiaxin Chen, Shuqing Wang, Qunyan Wu, Zhongzhen Su, Yuhong Lin

  • Journal: Abdominal Radiology

  • Year: 2025

4. Tertiary Lymphoid Structure Formation Induced by LIGHT-Engineered and Photosensitive Nanoparticles-Decorated Bacteria Enhances Immune Response Against Colorectal Cancer

  • Authors: Lijun Hu, Li Tan, Shaohui Deng, Honglin Gao, Yujie Jiang, Chen Qiu, Hui Chen, Zecong Xiao, Xintao Shuai, Zhongzhen Su

  • Journal: Biomaterials

  • Year: 2025

  • Citations: 6​

5. Histopathological Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma: Is It Reliable?

  • Authors: Liujun Li, Chaoqun Wu, Feile Ye, Zhou Xuan, Xiaoli Zhang, Jianping Li, Jia Zhou, Zhongzhen Su

  • Journal: World Journal of Gastroenterology

  • Year: 2025

6. Radiomics Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma Using 3D Ultrasound and Whole-Slide Image Fusion

  • Authors: Liujun Li, Shaodong Wang, Jiaxin Chen, Yao Lu, Zhongzhen Su

  • Journal: Small Methods

  • Year: 2025

7. Model Based on Ultrasound and Clinicopathological Characteristics for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

  • Authors: Xin Wen, Jiamin Chen, Jing Zhong, Yuhong Lin, Zhongzhen Su

  • Journal: Quantitative Imaging in Medicine and Surgery

  • Year: 2024

  • Citations: 1​

8. Development and Validation of an Individualized Nomogram for Predicting Patent Foramen Ovale-Associated Stroke: Patent Foramen Ovale Morphology-Based Analysis

  • Authors: Qin Zhang, Mochao Xiao, Wuzhu Lu, Zhongzhen Su, Xiaobo Chen

  • Journal: Echocardiography

  • Year: 2024

🧾 Conclusion

In summary, Dr. Zhongzhen Su stands out as a visionary ultrasound expert and medical educator, having redefined interventional standards in liver cancer therapy and fibrosis evaluation. His trailblazing research, prolific publication record, and dedication to clinical excellence make him an ideal nominee for the Best Researcher Award at the FORENSIC SCIENTIST AWARDS. 🏅🔍

Katia Collomp | Health Sciences | Women Researcher Award

Published on by Forensic Scientist

Prof. Dr. Katia Collomp | Health Sciences | Women Researcher Award

Professor, Orleans University | France

Professor Catherine (Katia) Collomp is a distinguished academic in Sport Sciences at the University of Orleans, France, and a Research Fellow at the French Antidoping Laboratory (LADF), University of Paris-Saclay. With an exceptional career dedicated to the intersection of pharmacology, exercise physiology, and anti-doping science, she is also a key member of the CIAMS laboratory. Her work has significantly influenced anti-doping policies and research ethics in sports science, making her a leading voice in the field.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Experience & Leadership
    Professor Collomp has over three decades of continuous and impactful contributions to sport sciences, pharmacology, and anti-doping research. Her role as a full professor and long-term research fellow at the French Antidoping Laboratory (LADF) demonstrates academic excellence and institutional commitment.

  • Interdisciplinary Expertise
    Her background as a pharmacist and researcher in physical activity and health sciences reflects a rare interdisciplinary blend that strengthens both the scientific rigor and practical impact of her work, especially in anti-doping studies—a field requiring deep knowledge of pharmacology, ethics, and sports physiology.

  • Global and National Collaborations
    Her postdoctoral research in Canada and continued collaborations with major institutions like University of Paris-Saclay and WADA position her as an internationally connected researcher. These connections indicate a high level of respect and trust in her expertise.

  • Institutional Service & Policy Impact
    Professor Collomp has held numerous leadership and advisory roles:

    • Co-director of the CIAMS lab team

    • Expert reviewer for HCERES

    • Member of ethics committees and national academic councils (CNU

🎓 Education

Katia Collomp began her academic journey by earning her degree in Pharmacy from the University of Montpellier I in 1987. She went on to complete her Ph.D. in 1991, focusing on “Physical activity, psychological and motor development” within the Life Sciences and Health section at the same university. 📘 Following her doctorate, she undertook a postdoctoral fellowship from 1992 to 1993 at the INRS Santé Antidoping Laboratory in Montréal, deepening her expertise in doping control and bioanalysis. She achieved her Habilitation à Diriger des Recherches (HDR) in 1997, establishing her as a senior scientific leader in her field.

💼 Experience

From 1993 to 1997, Katia served as a Pharmacist at the Mission Sports Medicine – Doping Control, Ministry of Sports in Paris, contributing to the foundation of anti-doping protocols. In 1997, she joined the French Antidoping Laboratory (LADF) as a Research Fellow, a position she continues to hold. Her academic path includes positions as Associate Professor (1997–2001) at the University of Paris XI and Full Professor (2001–present) at the University of Orleans. She has led multiple research teams and contributed to national committees on education and ethics.

🔬 Research Interest On Health Sciences

Her research interests span pharmacology, performance-enhancing substances, glucocorticoids, sports physiology, and rehabilitation. She focuses on the effects of physical activity on health and doping control, contributing to ethical frameworks and scientific methodologies that guide international sports policies. Her work helps shape understanding of how substances influence athletic performance and rehabilitation, playing a crucial role in global anti-doping efforts.

🏅 Awards & Honors

Professor Collomp has served in multiple national and international scientific committees, including as an expert for HCERES, a member of the WADA Glucocorticoids Threshold Working Group, and the Research Ethics Committee of Paris-Saclay (CER). She is currently a member of the French “Conseil National des Universités” (CNU 74), reflecting her respected status in the academic and sports science community. 🎖️ Her leadership and advocacy for scientific integrity in sports continue to influence generations of researchers and athletes alike.

📚 Publications

1. Hormonal and Metabolic Responses Across Phases of Combined Oral Contraceptive Use and Menstrual Cycle in Young Elite Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Caroline Teulier, Juliette Bonnigal, Nathalie Crépin, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: European Journal of Applied Physiology

  • DOI: 10.1007/s00421-025-05745-x

2. Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

  • Authors: Katia Collomp, Caroline Teulier, Carole Castanier, Juliette Bonnigal, Alexandre Marchand, Corinne Buisson, Magnus Ericsson, Nathalie Crépin, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2025

  • Journal: Drug Testing and Analysis

  • DOI: 10.1002/dta.3859

3. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: The Journal of Sports Medicine and Physical Fitness

  • DOI: 10.23736/s0022-4707.24.16488-2

4. Editorial: Women in Sports 2022

  • Authors: Katia Collomp, S. Lorenzetti

  • Year: 2024

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2024.1367605

5. Physical Activity and Female Students’ Perception of Menstrual Symptoms: Impact of Hormonal Contraception

  • Authors: Katia Collomp, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Valérie Bougault

  • Year: 2024

  • Conference Paper: HAL: hal-04936867

  • Citations: 0​

6. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Caroline Teulier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2024

  • Conference Paper: HAL: hal-04936872

7. Physical Activity and Combined Hormonal Contraception: Association with Female Students’ Perception of Menstrual Symptoms

  • Authors: Valérie Bougault, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2023.1185343

8. Short-Term Effect of Bariatric Surgery on Cardiorespiratory Response at Submaximal, Ventilatory Threshold, and Maximal Exercise in Women with Severe Obesity

  • Authors: Nancy Vibarel-Rebot, Marine Asselin, Virgile Amiot, Katia Collomp

  • Year: 2023

  • Journal: Obesity Surgery

  • DOI: 10.1007/s11695-023-06550-1

9. Summer Olympic Sports and Female Athletes: Comparison of Anti-Doping Collections and Prohibited Substances Detected in Australia and New Zealand vs. France

  • Authors: Corinne Buisson, L. Brooker, C. Goebel, R. Morrow, R. Chakrabarty, N. Speers, A. Molina, Magnus Ericsson, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2023.1213735

10. Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences

  • Authors: Katia Collomp, Magnus Ericsson, N. Bernier, Corinne Buisson

  • Year: 2022

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2022.839976

🔚 Conclusion

Professor Catherine Collomp exemplifies the union of scientific excellence, ethical integrity, and academic leadership in the field of sport sciences and pharmacology. Her dedication to clean sport, athlete health, and rigorous scientific inquiry continues to guide anti-doping practices across the globe. Her nomination for any award would reflect her lifelong commitment to advancing science in service of both health and fairness in athletics.